Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Ascentage Oncology Drug Effective in Preclinical Tests for COVID Cytokine Storm

RVAC Completes B Round for mRNA Drugs, Bringing Total Raised to $140 Million

Ascletis Reports Positive Preclinical Data from 3CLpro COVID Therapy

Everest Medicines Signs MOU with CR Pharma to Form mRNA Company

Kintor Reports ACE2 Inhibitor 100% Effective Against COVID-19 Hospitalization/Death

ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022